Natural resistance to HIV infection: Lessons learned from HIV-exposed uninfected individuals

Journal of Infectious Diseases

Volumn 202, Issue SUPP.3, 2010, Pages

  Pancino, Gianfranco ^a   Saez Cirion, Asier ^a   Scott Algara, Daniel ^a   Paul, Pascale ^b,c  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; NATURAL KILLER CELL RECEPTOR;

CD4+ T LYMPHOCYTE; CELL ACTIVITY; CONFERENCE PAPER; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; NATURAL KILLER CELL; NEEDLE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SPOUSE; T LYMPHOCYTE ACTIVATION; VIET NAM; VIRUS REPLICATION; VIRUS RESISTANCE; ARTICLE; CAMBODIA; CENTRAL AFRICAN REPUBLIC; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; VIROLOGY;

CAMBODIA; CENTRAL AFRICAN REPUBLIC; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; VIETNAM;

EID: 78049445214     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655973     Document Type: Conference Paper

References (26)

1. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078.
2. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-1351. (Pubitemid 26383775)
3. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725.
4. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994; 93:1293-1297.
5. Clerici M, Giorgi JV, Chou CC. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165:1012-1019.
6. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997; 3:1250-1257.
7. Miyazawa M, Lopalco L, Mazzotta F, Lo Caputo S, Veas F, Clerici M. The 'immunologic advantage' of HIV-exposed seronegative individuals. AIDS 2009; 23:161-175.
8. Truong TXL, Luong TT, Scott-Algara D, et al. CD4+ cell and CD8+ cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. AIDS 2003; 17:1-10.
9. Nguyen M, Pean P, Lopalco L, et al. HIV-specific antibodies but not T cell responses are associated to protection in seronegative partners of HIV-1 infected individuals in Cambodia. J Acquir Immune Defic Syndr 2006; 42:412-419.
10. Begaud E, Chartier L, Marechal V, et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006; 3:35.
11. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
12. Tran HK, Chartier L, Troung LX, et al. Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users. AIDS Res Hum Retroviruses 2006; 22:255-261.
13. + regulatory T cells. J Infect Dis 2009; 199:1318-1322.
14. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-377.
15. Saez-Cirion A, Versmisse P, Truong LX, et al. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks. Retrovirology 2006; 3:81.
16. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-434.
17. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39:733-740.
18. Carrington M, Martin MP, van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol 2008; 16:620-627.
19. Scott-Algara D, Truong LX, Versmisse P, et al. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 2003; 171:5663-5667.
20. Ravet S, Scott-Algara D, Bonnet E, et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007; 109:4296-4305.
21. Knapp S, Warshow U, Hegazy D, et al. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 2010; 51:1168-1175.
22. Mazzoli S, Lopalco L, Salvi A, et al. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J Infect Dis 1999; 180:871-875.
23. + responses. J Clin Invest 2001; 107:341-349.
24. Lehner T, Wang Y, Pido-Lopez J, Whittall T, Bergmeier LA, Babaahmady K. The emerging role of innate immunity in protection against HIV-1 infection. Vaccine 2008; 26:2997-3001.
25. Capitini CM, Fry TJ, Mackall CL. Cytokines as adjuvants for vaccine and cellular therapies for cancer. Am J Immunol 2009; 5:65-83.
26. Scott-Algara D, Mancini-Bourgine M, Fontaine H, Pol S, Michel ML. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. PLoS One 2010; 5:e8761.